S&P 500 futures hit record high on coronavirus vaccine hopes
|US equity futures rose sharply in the last hour after Pfizer announced that the coronavirus vaccine it's been developing with BioNTech was more than 90% effective.
Commenting on the results, "the efficacy data are really impressive. This is better than most of us anticipated. I would have been delighted with efficacy of 70% or 75%. 90% is very impressive for any vaccine," said William Schaffner, infectious diseases expert at Vanderbilt University Medical Center. "The study isn't completed yet, but nonetheless, the data look very solid."
With the initial market reaction, the S&P 500 futures surged to a fresh record high of 3,648 and was last seen gaining 3.73% at 3,631. Additionally, Dow E-minis were up 2.45% and Nasdaq 100 e-minis were up 2.2%. Finally, Russell 2000 hit the daily limit-up on this headline.
S&P 500 15-min chart
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.